Skip to content

SankoreAfrican research intelligence

Countries
Institutions
Fields
Rankings
Compare

Search institutions, scholars, countries and publications

Sankore

Named after the University of Sankore in Timbuktu — one of the world’s oldest centres of learning. Every figure here is computed from work-level records in our own graph, never copied from a source’s summary count.

Built from

OpenAlex — works, authorships, subject classification
ROR — institutional identity
ORCID — researcher identity
Crossref — publisher confirmation

Browse

Countries
Institutions
Fields
Rankings
What we cover

Coverage is partial and says so. A country appears with its research output only once its works have been swept; until then the portal shows whatever the graph happens to hold for it and labels it as exactly that.

Iris Mosweu · Sankore

Iris Mosweu

ORCID, self-asserted

ORCID 0000-0001-6797-2478

This profile carries an ORCID the researcher published on their own record — the strongest evidence available short of a human confirming it.

Publications

8

Citations

33

h-index

4

Computed over the works the graph holds, so it is a floor rather than a career figure.

i10-index

1

Publications

4 works in the graph, newest first.

Development of an integrated and decentralised skin health strategy to improve experiences of skin neglected tropical diseases and other skin conditions in Atwima Mponua District, Ghana
2024PLOS Global Public HealthJournalOpen access7 citations10.1371/journal.pgph.0002809
Buruli-RifDACC: Evaluation of the efficacy and cost-effectiveness of high-dose versus standard-dose rifampicin on outcomes in Mycobacterium ulcerans disease, a protocol for a randomised controlled trial in Ghana
2023NIHR Open ResearchJournalOpen access2 citations10.3310/nihropenres.13332.2
Additional files for BuruliRifDACC
2022Zenodo (CERN European Organization for Nuclear Research)JournalOpen access6 citations10.5281/zenodo.7263509
Buruli-RifDACC: Evaluation of the efficacy and cost-effectiveness of high-dose versus standard-dose rifampicin on outcomes in Mycobacterium ulcerans disease, a protocol for a randomised controlled trial in Ghana
2022NIHR Open ResearchJournalOpen access3 citations10.3310/nihropenres.13332.1